Results 291 to 300 of about 233,161 (342)

Laparoscopic Splenectomy for Inflammatory Pseudotumor‐Like Follicular Dendritic Cell Sarcoma: A RareEpstein–Barr Virus‐Associated Splenic Tumor

open access: yes
The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 2, February 2026.
Hsin‐Yi Lin   +3 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Epstein Barr Virus hepatitis

European Journal of Internal Medicine, 2011
Epstein-Barr Virus (EBV) infection has the potential to establish life-long, benign infections in their hosts. Although biochemical evidence of hepatocellular damage is common, jaundice is uncommon and complete recovery is the rule. The present study describes clinical characteristics and changes of liver function tests during the course of infectious ...
Diamantis P, Kofteridis   +6 more
openaire   +2 more sources

Epstein-Barr virus dacryoadenitis

American Journal of Ophthalmology, 2000
To describe the clinical features of lacrimal gland inflammation associated with Epstein-Barr virus infection.The clinical records, laboratory data, and radiographs of patients who had inflammation of one or both lacrimal glands that had begun less than 4 weeks previously were reviewed.Sixteen patients with dacryoadenitis were encountered between 1980 ...
M N, Rhem, K R, Wilhelmus, D B, Jones
openaire   +2 more sources

Das Epstein-Barr-Virus ( = Epstein-Barr virus)

1993
Epstein-Barr virus is an ubiquitous humanpathogenic herpesvirus. It has been identified as the etiologic agent of infectious mononucleosis. In addition it is associated with the cancers nasopharyngeal carcinoma and Burkitt's lymphoma. Like other herpesviruses it infects cells in a lytic way or it persists in a latent state.
Niller, H. H., Wolf, Hans J.
openaire   +2 more sources

Epstein-Barr Virus Infection

Pediatrics In Review, 1994
Introduction Virtually all humans become infected with Epstein-Barr virus (EBV). The vast majority of these infections are inapparent, occur early in life, and are associated with lifelong latent infection and persistent shedding of virus. Epidemiology The prevalence of antibody to EBV has been determined in
W A, Durbin, J L, Sullivan
openaire   +2 more sources

Epstein — Barr virus vaccines

Vaccine, 1992
Epstein-Barr virus (EBV) is a human viral pathogen of considerable importance. More than 95% of the human population world-wide becomes infected with the virus during childhood, although in the West infection may be delayed until adolescence. The infection only has an undesirable significant clinical outcome in a tiny minority of cases, but because the
openaire   +2 more sources

Epstein–Barr Virus Infection

New England Journal of Medicine, 2000
The Epstein–Barr virus (EBV) was discovered 36 years ago by electron microscopy of cells cultured from Burkitt's lymphoma tissue by Epstein, Achong, and Barr.1 Four years later, in 1968, EBV was shown to be the etiologic agent of heterophile-positive infectious mononucleosis.2 EBV DNA was detected in tissues from patients with nasopharyngeal carcinoma ...
openaire   +2 more sources

[Epstein-Barr virus].

Annales de medecine interne, 1998
The Epstein-Barr virus (EBV), which predominantly infects B-cells, has certain novel features, particularly its ability to remain latent for long periods and its capacity for transformation. Host immune response is complex, varying in intensity and quality. Disease expression results from this conflict between the host and the virus.
J C, Nicolas, V, Maréchal, A, Dehée
  +6 more sources

Home - About - Disclaimer - Privacy